|
|
|
|
LEADER |
00000csc a2200000 a 4500 |
001 |
25757-1 |
005 |
20230308214423.0 |
008 |
998102|1997 ||||||||r|||||||||||spa|| |
020 |
|
|
|a 9701016033
|
040 |
|
|
|b spa
|
041 |
1 |
|
|a spa
|
082 |
0 |
|
|a 618.9
|
245 |
|
|
|a Nuevas fronteras de la farmacoterapia
|c Benoit Bailey y Gideon Koren directores; José Rafael Blengio traductor
|h imp
|n 1/6
|
264 |
|
|
|a México
|b McGraw-Hill Interamericana
|c 1997
|
300 |
|
|
|a XIV pp 1-283
|b ilu
|
300 |
|
|
|c 22x16 cm
|
310 |
|
|
|a Bimestral
|
490 |
|
|
|a Clínicas Pediátricas de Norteamérica
|v volumen 1/6
|
504 |
|
|
|a incl. ref.
|
650 |
1 |
|
|a Pediatria
|9 2161
|
650 |
1 |
|
|a Quimioterapia
|9 2341
|
650 |
|
|
|a Consumo de fármacos
|9 297886
|
650 |
|
|
|a Farmacogenética en pediatría
|9 297887
|
650 |
|
|
|a Niñez temprana
|9 50274
|
650 |
|
|
|a Farmacoterapia fetal
|9 297888
|
650 |
|
|
|a Autorregulación sanguínea
|9 297889
|
650 |
|
|
|a Sepsis en niños
|9 297890
|
650 |
|
|
|a Deferiprona
|9 297891
|
650 |
|
|
|a Bronquiolitis
|9 297892
|
650 |
|
|
|a Laringitis
|9 297893
|
700 |
1 |
|
|a Blengio, José Rafael, trad.
|9 296997
|
773 |
|
|
|t Nuevas fronteras de la farmacoterapia
|
852 |
|
|
|a UC-SALUD
|c ESTANTERIA ABIERTA
|f Compra
|k teresa.bermeoh
|l 1
|m General
|p 19981029/20130424
|q S/. 218.055
|t 25757-1
|b 0
|d CDRS
|e CDRS
|g 618.9 ESTANTERIA ABIERTA
|z 1998-81-02
|
942 |
|
|
|
999 |
|
|
|c 128559
|d 128559
|